Review
Jul 2026
Precision targeting in prostate cancer: Mechanistic drivers and the evolving clinical pipeline.
Prostate cancer (PC) is one of the most common cancers among males worldwide, and its curative treatment is challenging. This review discusses pathways-including androgen receptor signalling, prostate-specific membrane antigen, DNA damage repair, neuroendocrine differentiation targets, metabolic reprogramming, Wnt/β-ca...
Pratiksha Nathe, Yogesh Singh, Pooja Ratre et al.
· Drug Discovery Today · 0 citations